Articles From: Celsion's ThermoDox Plus High Intensity Focused Ultrasound Highlighted at 14th International Symposium on Therapeutic Ultrasound to CEMEX Announces Offering of Senior Secured Notes


2014/4/9
Data Supports Development as Non-Invasive Treatment Regimen in a Variety of Cancer Indications LAWRENCEVILLE, N.J. , April 9, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today that data supporting the development of ThermoDox®, its proprietary heat-activated liposomal encapsulation of doxorubicin, plus high intensity focused ultrasound (HIFU) were presented on April 5, 2014 at the 14th International Symposium on Therapeutic Ultrasound in Las Vegas , Nevada.
Sign-up for Celsion's ThermoDox Plus High Intensity Focused Ultrasound Highlighted at 14th International Symposium on Therapeutic Ultrasound investment picks
2014/1/30
NEW YORK and LONDON, Jan.
Sign-up for Celsus Therapeutics Announces Pricing of Public Offering and Listing on NASDAQ investment picks
2013/10/2
NEW YORK and LONDON, Oct.
Sign-up for Celsus Therapeutics Names Allan Shaw to Board of Directors investment picks
2014/4/7
NEW YORK and LONDON, April 7, 2014 (GLOBE NEWSWIRE) -- Celsus Therapeutics Plc (Nasdaq:CLTX) , an emerging growth, development-stage biotech company, announced today the formation of a new Dermatology Scientific Advisory Board (SAB). The SAB is comprised of: Jonathan Wilkin, MD, founding director (retired) of the Division of Dermatology and Dental Products at the US Food and Drug Administration (FDA); Amy Paller, MD, Walter J.
Sign-up for Celsus Therapeutics Plc Announces Formation of New Dermatology Scientific Advisory Board investment picks
2014/3/31
NEW YORK and LONDON, March 31, 2014 (GLOBE NEWSWIRE) -- Celsus Therapeutics Plc (Nasdaq:CLTX) , an emerging growth, development-stage biotech company, announced today that Dr.
Sign-up for Celsus Therapeutics Plc to Present at the 13th Annual Needham Healthcare Conference investment picks
2014/3/11
Celsus completes Type B pre-IND meeting with FDA for MRX-6 cream in atopic dermatitis MRX-6 to advance into Phase II trials in US upon filing of IND expected in 4Q14 NEW YORK and LONDON, March 11, 2014 (GLOBE NEWSWIRE) -- Celsus Therapeutics Plc (Nasdaq:CLTX) , an emerging growth, development-stage biotech company, announced today that it held a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) on February 12 th , 2014, to discuss the regulatory pathway for the development of MRX-6 cream in atopic dermatitis, also known as eczema, an inflammatory skin disorder affecting 5% to 20% of children world-wide.
Sign-up for Celsus Therapeutics Provides Update on MRX-6 From FDA Pre-IND Meeting investment picks
2014/3/24
NEW YORK and LONDON, March 24, 2014 (GLOBE NEWSWIRE) -- Celsus Therapeutics Plc (Nasdaq:CLTX) , an emerging growth, development-stage biotech company, today announced its financial results and provided a review of the twelve month period ended December 31, 2013.
Sign-up for Celsus Therapeutics Provides Year End 2013 Financial Results and Corporate Highlights investment picks
2014/2/6
NEW YORK and LONDON, Feb.
Sign-up for Celsus Therapeutics to Present at the 2014 BIO CEO & Investor Conference investment picks
FARMINGDALE, N.Y. , Jan.
Sign-up for Cement Manufacturers to buy Emission Monitors for Compliance with EPA's MACT Rule investment picks
2013/10/28
Cementos Pacasmayo S.A.A. (NYSE: CPAC; BVL: CPACASC1) (“the Company” or “Cementos Pacasmayo”) announced today that at a Board meeting held on October 25, 2013, the Company's Board of Directors approved a cash dividend of S/. 0.10 per common and investment share, which represents a total of S/. 58,196,460.30 related to net income as of September 30, 2013, in accordance with what was authorized at the Board of Directors meeting held on March 26, 2013.
Sign-up for Cementos Pacasmayo S.A.A. Announces Annual Dividend Payment investment picks
2014/2/13
Cementos Pacasmayo S.A.A. and subsidiaries (NYSE: CPAC; BVL: CPACASC1) (“the Company” or “Cementos Pacasmayo”) a Peruvian cement company, announced today its consolidated results for the fourth quarter (“4Q13”) and twelve months (“2013”) ended December 31, 2013.
Sign-up for Cementos Pacasmayo S.A.A. Announces Consolidated Results for Fourth Quarter 2013 investment picks
Cementos Pacasmayo S.A.A. and subsidiaries (NYSE: CPAC; BVL: CPACASC1) (“the Company” or “Cementos Pacasmayo”) a leading Peruvian cement company, announced today its consolidated results for the second quarter (“2Q13”) and six-month (“6M13”) periods ended June 30, 2013.
Sign-up for Cementos Pacasmayo S.A.A. Announces Consolidated Results for Second Quarter 2013 investment picks
2013/10/28
Cementos Pacasmayo S.A.A. and subsidiaries (NYSE: CPAC; BVL: CPACASC1) (“the Company” or “Cementos Pacasmayo”) a leading Peruvian cement company, announced today its consolidated results for the third quarter (“3Q13”) and first nine months (“9M13”) periods ended September 30, 2013.
Sign-up for Cementos Pacasmayo S.A.A. Announces Consolidated Results for Third Quarter 2013 investment picks
2014/2/14
Cementos Pacasmayo S.A.A. (NYSE: CPAC; BVL: CPACASC1) (“Cementos Pacasmayo” or the “Company”) in accordance with CONASEV Resolution for Material Events, Reserved Information and Other Communications N° 107-2002-EF/94.10, announces the following: The Company’s Board of Directors, in its session held on February 13, 2014, agreed unanimously to call an Annual Shareholders’ Meeting, to be held at Calle La Colonia No 150, Urb.
Sign-up for Cementos Pacasmayo S.A.A. Announces Its Annual Shareholders’ Meeting Agenda investment picks
2014/3/26
Cementos Pacasmayo S.A.A. (NYSE:CPAC; BVL:CPACASC1) (“Cementos Pacasmayo” or the “Company”) a Peruvian cement company, announced today that the Annual Shareholders’ Meeting held on March 25, 2014 at 10:00 am (Peruvian time), approved by majority vote the following: About Cementos Pacasmayo S.A.A. Cementos Pacasmayo S.A.A. is a Peruvian cement company located in the Northern region of Peru.
Sign-up for Cementos Pacasmayo S.A.A. Announces Resolutions Adopted at the Annual Shareholders’ Meeting investment picks
2014/2/13
LIMA, Peru , Feb.
Sign-up for Cementos Pacasmayo To Host Fourth Quarter 2013 Earnings Conference Call & Audio Webcast investment picks
2013/10/28
LIMA, Peru , Oct.
Sign-up for Cementos Pacasmayo to Host Third Quarter 2013 Earnings Conference Call & Audio Webcast investment picks
CEMEX (NYSE:CX) and Concrete Supply Co.
Sign-up for CEMEX and Concrete Supply Co. Announce Joint Venture investment picks
CEMEX S.A.B. de C.V., (NYSE: CX) announced today that it will sign an agreement with the United Nations Foundation to join its Global Alliance for Clean Cookstoves, a public-private partnership that seeks to save lives, protect the environment and improve the quality of life of local communities, by creating a thriving global market for clean and efficient household cooking solutions.
Sign-up for CEMEX and the UN Foundation Sign Agreement to Improve Quality of Life in Emerging Countries investment picks
2013/10/9
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today that holders of approximately €179 million of the outstanding 9.625% Senior Secured Notes due 2017 (the “2017 Notes”) issued by CEMEX Finance LLC tendered their 2017 Notes at or prior to the early tender deadline of 5:00 p.m., New York City time, on October 8, 2013 (the “Early Tender Date”), pursuant to CEMEX’s previously announced cash tender offer to purchase up to €220 million (the “Maximum Tender Amount”) of the outstanding 2017 Notes.
Sign-up for CEMEX Announces Acceptance for Purchase of €179 Million of 9.625% Notes Due 2017 and Early Settlement of Tender Offer investment picks
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today that holders of approximately U.S.$1.33 billion of the outstanding 9.50% Senior Secured Notes due 2016 (the “Notes”) issued by CEMEX Finance LLC tendered their Notes at or prior to the early tender deadline of 5:00 p.m., New York City time, on August 16, 2013 (the "Early Tender Date"), pursuant to CEMEX's previously announced cash tender offer to purchase up to U.S.$925 million (the “Maximum Tender Amount”) of the outstanding Notes.
Sign-up for CEMEX Announces Acceptance for Purchase of U.S. $925 Million of 9.50% Notes Due 2016 and Early Settlement of Tender Offer investment picks
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE:CX) announced today that holders of approximately U.S.$470 million of the outstanding 9.50% Senior Secured Notes due 2016 (the “2016 Notes”) issued by CEMEX Finance LLC tendered their 2016 Notes at or prior to the early tender deadline of 5:00 p.m., New York City time, on October 8, 2013 (the "Early Tender Date"), pursuant to CEMEX's previously announced cash tender offer to purchase any and all of the outstanding 2016 Notes.
Sign-up for CEMEX Announces Acceptance for Purchase of U.S.$470 Million of 9.50% Notes Due 2016 and Early Settlement of Tender Offer investment picks
2014/4/10
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today that it has successfully completed the financing of Ventika, a project comprising the construction of two 126 MW wind farms each, for a total nominal capacity of 252 MW to be located in General Bravo, Nuevo Leon, Mexico.
Sign-up for CEMEX Announces Completion of Financing of One of the Largest Wind Farm Projects in Latin America investment picks
2014/4/8
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today that holders of U.S.$597,153,000 of the outstanding 9.250% Senior Secured Notes due 2020 (the “2020 Notes”) issued by CEMEX España, S.A., acting through its Luxembourg Branch, and U.S.$602,580,000 of the outstanding 9.000% Senior Secured Notes due 2018 (the “2018 Notes” and, together with the 2020 Notes, the “Notes”) issued by CEMEX tendered their Notes at or prior to the early tender deadline of 5:00 p.m., New York City time, on April 7, 2014 (the “Early Tender Date”), pursuant to CEMEX Finance LLC’s (“CEMEX Finance”) previously announced cash tender offer (the “Tender Offer”) to purchase up to U.S.$1,080 million (the “Aggregate Maximum Tender Amount”) of the outstanding Notes.
Sign-up for CEMEX Announces Early Tender Results for Certain Senior Secured Notes and Early Settlement of Tender Offer investment picks
2013/10/24
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today the expiration of its previously announced cash tender offer to purchase any and all of the outstanding 9.50% Senior Secured Notes due 2016 (the “2016 Notes”) issued by CEMEX Finance LLC.
Sign-up for CEMEX Announces Expiration of Its Tender Offer for 9.50% Notes Due 2016 investment picks
2013/10/24
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today the expiration of its previously announced cash tender offer to purchase up to €220 million of the 9.625% Senior Secured Notes due 2017 (the “2017 Notes”) issued by CEMEX Finance LLC.
Sign-up for CEMEX Announces Expiration of Its Tender Offer for 9.625% Notes Due 2017 investment picks
2013/10/3
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today that it is increasing the maximum amount (the "Maximum Tender Amount") of the 9.625% Senior Secured Notes due 2017 (the “2017 Notes”), issued by CEMEX Finance LLC, that it is seeking to purchase for cash pursuant to its previously announced tender offer (the “Tender Offer”) to €220,000,000, from the original amount of €150,000,000. Full details of the terms and conditions of the Tender Offer are included in CEMEX's offer to purchase, dated September 25, 2013, as amended and supplemented by the supplement, dated October 3, 2013 (the "Offer to Purchase"), relating to the 2017 Notes.
Sign-up for CEMEX Announces Increase of Previously Announced Tender Offer for 9.625% Notes Due 2017 investment picks
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today its intention to offer a new series of senior secured notes (the “Notes”) denominated in U.S. dollars, subject to market and other conditions.
Sign-up for CEMEX Announces Offering of Senior Secured Notes investment picks
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today its intention to offer senior secured notes in one or more series (the “New Notes”) denominated in U.S. dollars, subject to market and other conditions.
Sign-up for CEMEX Announces Offering of Senior Secured Notes investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Celsion's ThermoDox Plus High Intensity Focused Ultrasound Highlighted at 14th International Symposium on Therapeutic Ultrasound to CEMEX Announces Offering of Senior Secured Notes
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity